Synergy Life Science Partners
Overview
Synergy Life Science Partners is a venture capital firm specializing in early-stage investments in medical device and combination product companies across the United States. The firm focuses on large therapeutic areas, including cardiovascular, orthopedics and spine, ophthalmology, metabolic disorders such as obesity and diabetes, oncology, gastrointestinal diseases, and respiratory diseases. Their investment strategy involves a synergistic approach with entrepreneurs, providing capital allocation and access to a network of technical, clinical, and operational expertise to build companies effectively. The firm has a track record of investing in companies like Barosense, Oraya Therapeutics, and NeuroTronik, demonstrating its commitment to advancing healthcare solutions through strategic partnerships.
Investment Focus
- Early-stage medical device and combination product companies in the United States
Portfolio Companies
Reach Synergy Life Science Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Synergy Life Science Partners
What sectors does Synergy Life Science Partners invest in?
Synergy Life Science Partners invests in Healthcare, Biotechnology, Pharmaceutical, Therapeutics, Health Diagnostics and Medical Device, and is based in California, United States. Synergy Life Science Partners is listed as a venture capital in the ConnectSafely investor database.
What stage does Synergy Life Science Partners invest at?
Synergy Life Science Partners backs companies at Early Stage.
Which regions does Synergy Life Science Partners invest in?
Synergy Life Science Partners invests across United States.
What companies has Synergy Life Science Partners invested in?
Synergy Life Science Partners's portfolio includes Barosense, Oraya Therapeutics and NeuroTronik.
Last updated · Source: ConnectSafely investor database